Valuable experience, but lacking in leadership and growth - Recensione dipendente - Dipendente anonimo presso Crown Bioscience

2,0
28 lug 2025
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

- Gained valuable hands-on lab experience - Some coworkers were helpful and knowledgeable - Opportunity to work independently on routine tasks

Svantaggi

- Poor communication from leadership, often unclear expectations - Little to no feedback or recognition for work - Very limited opportunities for growth or development - Work environment could feel rigid and unmotivating

Esplora altre recensioni su Crown Bioscience

5,0
16 ott 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

small company with warm atmosphere

Svantaggi

average pay, legal and HR are less experienced

1,0
23 mag 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Crown Bioscience has real scientific assets, capable technical teams, and a portfolio that should be much stronger than it is. There are smart, hardworking people across the organization who want to do good work and serve clients well. The company has legitimate strengths in oncology models, translational services, and scientific execution.

Svantaggi

The biggest problem is leadership. The company’s potential is undermined by a culture that rewards control, internal politics, and performative alignment over clear strategy, accountability, and commercial execution. In my experience, senior leadership created an environment where dissent was treated as disloyalty, questions were reframed as attitude problems, and employees were expected to manage upward around fragile, insecure egos rather than focus on customers, products, and growth. One senior leader in particular operated less like an executive partner and more like a line manager obsessed with correction, control, and public positioning. The result was a workplace where people learned to self-censor, over-document, and avoid risk rather than solve problems directly. There was a serious gap between the company’s stated ambition and its operating reality. Commercial strategy was fragmented. Priorities shifted without disciplined governance. Roadmaps were more performative than actionable. Cross-functional work often depended on personalities rather than process. Instead of empowering experienced people to fix obvious business issues, leadership seemed more interested in protecting turf and controlling narratives. The most damaging part was the disconnect between the quality of the scientific platform and the quality of the management culture. Crown Bio has enough technical capability to compete meaningfully, but it is held back by weak organizational discipline, unclear decision rights, lack of accountability, and leaders who appear threatened by directness, expertise, or independent judgment. This is not a place I would recommend for anyone who expects real ownership. If you are looking for a role where you can diagnose problems, build structure, challenge assumptions, and drive execution, be careful. The organization may say it wants transformation, but the culture does not consistently support the kind of candor and autonomy transformation requires.

Vedi recensioni per: Utile|Valutazione|Data|Tutto